Evidence map›Paper›PMID 40317303›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

PET imaging utilization and trends in Germany: a comprehensive survey.

Adrien Holzgreve, Dirk Hellwig, Henryk Barthel, Ambros J Beer, Carsten Kobe, Constantin Lapa, Matthias Miederer, Sarah Schwarzenböck, Robert Seifert, Andrei Todica and 6 more

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Adsorption treatment ofAnnals of nuclear medicine · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Adrien HolzgrevePET Committee of the German Society of Nuclear Medicine, Göttingen, Germany. Adrien.Holzgreve@med.lmu.de.ORCID 0000-0002-9566-8438
Dirk HellwigPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Henryk BarthelPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Ambros J BeerPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Carsten KobePET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Constantin LapaPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Matthias MiedererPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Sarah SchwarzenböckPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Robert SeifertPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Andrei TodicaPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.
Ken HerrmannDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Frank M BengelDepartment of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Michael SchäfersDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Detlef MokaNuclear Medicine Centre, Essen, Germany.
Markus LusterDepartment of Nuclear Medicine, Philipps University of Marburg, Marburg, Germany.
Wolfgang P FendlerPET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPET imaging is a key diagnostic procedure in clinical routine worldwide. While public figures on PET volume are available in many countries, until now these numbers were not publicly known for Germany.

methodsOn behalf of the PET committee of the German Society of Nuclear Medicine, we conducted a comprehensive survey among PET centers in Germany to collect data on PET imaging, including the total PET volume and indication groups.

resultsNational total PET volume in 2021 was 154,400 scans (94% PET/CT, 6% PET/MRI). PET volume in 2021 normalized to total population was lower in Germany (1,857 scans per 1 million inhabitants) when compared to public figures from France (10,182 scans), Belgium (9,866 scans), or Italy (4,312 scans). PET volume in Germany demonstrated significant growth 2017 to 2021 (+ 48%). Top three indication fields were oncological (re)staging (76%), theranostic (13%), and neurology (4%). The top three indications were lung cancer (31%), prostate cancer (16%), and lymphoma/leukemia (12%). The top three radiotracers used were [

conclusionsClinical adoption of PET imaging in Germany is behind compared to Italy, France, and Belgium. However, newly established outpatient reimbursement seems to contribute to recent growth in PET volume. We observe considerable shift towards theranostic applications.

Indexed as

Positron-Emission TomographyGermanyHumansSurveys and QuestionnairesClinical practice and health policyEuropean union (EU)GermanyPositron emission tomography (PET) volumeSurvey

Identifiers

PMID40317303
PMCPMC12491347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.